PL3431490T3 - Związki chemiczne mające zastosowanie jako markery diagnostyczne stanu zapalnego i nowotworów, sposób ich otrzymywania, zestaw diagnostyczny i metoda diagnozowania procesów zapalnych i nowotworów nabłonkowych - Google Patents
Związki chemiczne mające zastosowanie jako markery diagnostyczne stanu zapalnego i nowotworów, sposób ich otrzymywania, zestaw diagnostyczny i metoda diagnozowania procesów zapalnych i nowotworów nabłonkowychInfo
- Publication number
- PL3431490T3 PL3431490T3 PL18183815T PL18183815T PL3431490T3 PL 3431490 T3 PL3431490 T3 PL 3431490T3 PL 18183815 T PL18183815 T PL 18183815T PL 18183815 T PL18183815 T PL 18183815T PL 3431490 T3 PL3431490 T3 PL 3431490T3
- Authority
- PL
- Poland
- Prior art keywords
- chemical compounds
- diagnostic
- inflammatory processes
- epithelial neoplasms
- neoplams
- Prior art date
Links
- 230000004054 inflammatory process Effects 0.000 title 3
- 208000034179 Neoplasms, Glandular and Epithelial Diseases 0.000 title 2
- 150000001875 compounds Chemical class 0.000 title 2
- 238000009007 Diagnostic Kit Methods 0.000 title 1
- 206010061218 Inflammation Diseases 0.000 title 1
- 230000015572 biosynthetic process Effects 0.000 title 1
- 238000003745 diagnosis Methods 0.000 title 1
- 238000002405 diagnostic procedure Methods 0.000 title 1
- 238000000338 in vitro Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1019—Tetrapeptides with the first amino acid being basic
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL422233A PL238575B1 (pl) | 2017-07-17 | 2017-07-17 | Związek oraz jego zastosowanie do wykrywania nowotworów nabłonkowych |
| PL426332A PL236125B1 (pl) | 2018-07-14 | 2018-07-14 | Związki chemiczne mające zastosowanie jako markery diagnostyczne stanu zapalnego i nowotworów, sposób ich otrzymywania, marker diagnostyczny i metoda diagnozowania procesów zapalnych i nowotworów nabłonkowych |
| EP18183815.2A EP3431490B1 (en) | 2017-07-17 | 2018-07-16 | Chemical compounds for use as diagnostic markers of inflammation and neoplams, the method for synthesis of the chemical compounds, diagnostic kit for use in diagnosis of inflammatory processes and epithelial neoplasms and in vitro diagnostic method of inflammatory processes and epithelial neoplasms |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3431490T3 true PL3431490T3 (pl) | 2020-09-07 |
Family
ID=63490142
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL18183815T PL3431490T3 (pl) | 2017-07-17 | 2018-07-16 | Związki chemiczne mające zastosowanie jako markery diagnostyczne stanu zapalnego i nowotworów, sposób ich otrzymywania, zestaw diagnostyczny i metoda diagnozowania procesów zapalnych i nowotworów nabłonkowych |
Country Status (2)
| Country | Link |
|---|---|
| EP (1) | EP3431490B1 (pl) |
| PL (1) | PL3431490T3 (pl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3987050A1 (en) | 2019-06-24 | 2022-04-27 | Urteste S.A. | Novel diagnostic marker for pancreatic cancer |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003064620A2 (en) * | 2002-01-31 | 2003-08-07 | Irm, Llc | Hepsin substrates and prodrugs |
| EA200801822A1 (ru) * | 2008-06-19 | 2009-04-28 | Ано "Институт Молекулярной Диагностики" | Тест-система для диагностики рака предстательной железы и способ диагностики рака предстательной железы |
| PL225341B1 (pl) * | 2014-07-17 | 2017-03-31 | Univ Gdański | Nowy związek, sposób jego otrzymywania, roztwór farmaceutyczny zawierający nowy związek, sposób określania obecności choroby nowotworowej, zestaw do wykrywania nowotworów oraz zastosowanie hydrolizy nowego związku do wykrywania nowotworów |
-
2018
- 2018-07-16 EP EP18183815.2A patent/EP3431490B1/en active Active
- 2018-07-16 PL PL18183815T patent/PL3431490T3/pl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3431490A1 (en) | 2019-01-23 |
| EP3431490B1 (en) | 2020-03-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202003200B (en) | Compositions, methods, and systems for the synthesis and use of imaging agents | |
| CL2016000883A1 (es) | Compuestos macrocíclicos, inhibidores de antígeno prostático específico de membrana (psma); composición farmacéutica; complejo de metal; y su uso para preparar compuestos radiomarcados útiles para la formación de imágenes para diagnosticar y para el tratamiento de cáncer de próstata y/o metástasis de la misma. | |
| ZA201903184B (en) | Compositions, methods, and systems for the synthesis and use of imaging agents | |
| EP3041955A4 (en) | Compositions and methods for diagnosis and prediction of solid organ graft rejection | |
| WO2015153513A8 (en) | Anti-ox40 antibodies and methods of use | |
| WO2016086036A3 (en) | Methods and compositions for 18f-radiolabeling of biologics | |
| WO2015153816A3 (en) | Methods and systems for cancer diagnosis and prognosis | |
| GB201303936D0 (en) | Methods and Compositions for the Diagnosis of Alzheimers Disease | |
| EP3232198A4 (en) | Biomarker for diagnosis of hepatoma and use thereof | |
| WO2015092393A3 (en) | Ligands specifically binding to human targets of interest | |
| HUE054864T2 (hu) | In vitro módszer tüdõrák diagnosztizálására | |
| EP3045911A4 (en) | Apparatus for manufacturing diagnosis kit, and diagnosis kit manufactured by same | |
| IL236197A0 (en) | In vitro method for the diagnosis and surveillance of cancer | |
| EP3359696A4 (en) | DIAGNOSTIC TEST FOR URINE MONITORING OF BUBBLE CANCER | |
| SG11201800677UA (en) | Transparent porous sustained-release body and method for producing the same, and kit of sustained-release body, sustained-release apparatus, and sustained-release method | |
| WO2013106747A3 (en) | Methods and compositions for the treatment and diagnosis of thyroid cancer | |
| WO2016094374A8 (en) | Compositions and methods for treatment of friedreich's ataxia | |
| IL272372A (en) | Substrate, metrology apparatus and associated methods for a lithographic process | |
| EP3304041A4 (en) | Methods of assessing cellular breast samples and compositions for use in practicing the same | |
| IT201700111939A1 (it) | Composizione farmaceutica per l’uso nel trattamento di stati infiammatori | |
| ZA201803250B (en) | New 5-azido-5-deoxy-2 :3-isopropylidene-d-arabinose compounds; their method of manufacture and their use for the synthesis of ara-n3, kdo-n3 and 4ekdo-n3 | |
| WO2014145035A8 (en) | Methods of making cancer compositions | |
| SI3629939T1 (sl) | Komplet in metoda za zbiranje urina | |
| EP3309551A4 (en) | Novel biomarker for diagnosing resistance to anticancer agent for biliary tract cancer and use thereof | |
| IL269094A (en) | Antibodies against eutaxin 2 for use in the treatment of liver diseases |